Registo em formato MARC
MFN: 8115
Identificador: 0b83b851-daa7-410f-ba79-6882a9057ca4
Formato: UNIMARC
Tipo de documento: BOOK
Criado em: 2015-01-28 09:43:57
Alterado em: 2015-02-02 14:06:03
001 SER+20150128094254
100   ^a20150128d2010    k  y0porb0103    ba
101 0 ^aeng
102   ^aZA
200 1 ^aThe SAPIT trial provides essential  evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis^fQuarraisha Abdool Karim...[et al.]
461  1^tSouth African Medical Journal (SAMJ)^cCidade do Cabo^bHealth and Medical Publishing Group^d2010^vvol. 100, nº 12^ppp. 808-809^x0256-9574
606   ^aDoente seropositivo^2SER+
606   ^aTuberculose^2SER+
606   ^aTratamento anti retrovírico^2SER+
606   ^aEnsaios clínicos^2SER+
606   ^aSAPIT trial
700  1^aKarim, ^bQuarraisha Abdool
701  1^aKarim,^bSalim S. Abdool^4070
701  1^aBaxter, ^bCheryl ^4070
701  1^aFriedland, ^bGerald ^4070
701  1^aGengiah,^bTanuja^4070
701  1^aGray,^bAndrew^4070
701  1^aGrobler,^bAnneke^4070
701  1^aNaidoo, ^bKogieleum^4070
701  1^aPadayatchi,^bNesri ^4070
701  1^aEl-Sadr,^bWafaa ^4070
856   ^u/BiblioNET/Upload/PDF8/006452_SAMJ 0113_v100n12a15.pdf^zTexto em PDF
920 n
921 a
922 a
931 20150128
932 d
933 2010
935 k  
936 y
937 0
938 ba